Theophylline disposition–effects of cimetidine, mebendazole and albendazole (1988)

Peer-Reviewed Study · Adebayo GI; Mabadeje AF · August 1988

Adebayo GI et al., 1988-08: Volunteer study testing whether benzimidazoles inhibit hepatic cytochrome P450: mebendazole 100 mg twice daily for three days did not change theophylline disposition, while cimetidine did – evidence that mebendazole's metabolic-inhibition effect is weak at standard doses.

Mebendazole at a dose of 100 mg b.d. for 3 days did not significantly alter the theophylline half-life, volume of distribution or clearance in a group of six.

Adebayo GI et al., 1988-08: Volunteer study testing whether benzimidazoles inhibit hepatic cytochrome P450: mebendazole 100 mg twice daily for three days did not change theophylline disposition, while cimetidine did – evidence that mebendazole's metabolic-inhibition effect is weak at standard doses.